We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+38.56%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$509M
AUM Growth
+$26M
Cap. Flow
-$46M
Cap. Flow %
-9.03%
Top 10 Hldgs %
10.09%
Holding
388
New
139
Increased
33
Reduced
62
Closed
144

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$3.68M
2
RRGB icon
Red Robin
RRGB
+$3.46M
3
INTA icon
Intapp
INTA
+$3.34M
4
OI icon
O-I Glass
OI
+$3.16M
5
PDFS icon
PDF Solutions
PDFS
+$2.91M

Sector Composition

Rank Sector Weight
1 Healthcare 25%
2 Technology 21.39%
3 Industrials 20.38%
4 Consumer Discretionary 11.68%
5 Energy 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCVX icon
126
Vaxcyte
PCVX
$8.64B
$1.87M 0.37%
49,863
-14,962
-23% -$635K
SMCI icon
127
Super Micro Computer
SMCI
$20.1B
$1.86M 0.37%
174,750
-135,820
-44% -$1.23M
WYNN icon
128
Wynn Resorts
WYNN
$10.6B
$1.86M 0.37%
+16,602
New +$1.74M
LSCC icon
129
Lattice Semiconductor
LSCC
$18.5B
$1.86M 0.36%
19,452
-914
-4% -$75.3K
PLRX icon
130
Pliant Therapeutics
PLRX
$65M
$1.84M 0.36%
+69,292
New +$1.97M
BDC icon
131
Belden
BDC
$5.19B
$1.84M 0.36%
21,214
+2,351
+12% +$195K
SPOK icon
132
Spok Holdings
SPOK
$241M
$1.83M 0.36%
+180,912
New +$1.65M
GFF icon
133
Griffon
GFF
$4.86B
$1.82M 0.36%
56,903
-34,178
-38% -$1.25M
NVEC icon
134
NVE Corp
NVEC
$609M
$1.8M 0.35%
21,740
-4,112
-16% -$307K
SKY icon
135
Champion Homes
SKY
$5.14B
$1.78M 0.35%
+23,682
New +$1.53M
XPRO icon
136
Expro Ltd
XPRO
$1.91B
$1.78M 0.35%
+96,892
New +$1.9M
CRUS icon
137
Cirrus Logic
CRUS
$6.26B
$1.75M 0.34%
+16,026
New +$1.56M
PRTA icon
138
Prothena Corp
PRTA
$459M
$1.75M 0.34%
36,156
-17,190
-32% -$908K
FCN icon
139
FTI Consulting
FCN
$4.18B
$1.72M 0.34%
+8,733
New +$1.52M
MG icon
140
Mistras Group
MG
$512M
$1.72M 0.34%
+254,079
New +$1.39M
PAYS icon
141
Paysign
PAYS
$698M
$1.71M 0.34%
471,821
+53,346
+13% +$182K
AKRO
142
DELISTED
Akero Therapeutics
AKRO
$1.71M 0.34%
44,687
-8,825
-16% -$393K
PBPB
143
DELISTED
Potbelly
PBPB
$1.7M 0.33%
+204,561
New +$1.54M
GENC icon
144
Gencor Industries
GENC
$212M
$1.68M 0.33%
+109,606
New +$1.37M
GATO
145
DELISTED
Gatos Silver, Inc.
GATO
$1.68M 0.33%
+256,939
New +$1.24M
LMNR icon
146
Limoneira
LMNR
$251M
$1.67M 0.33%
+100,470
New +$1.47M
GHM icon
147
Graham Corp
GHM
$1.31B
$1.67M 0.33%
+127,693
New +$1.55M
CLDX icon
148
Celldex Therapeutics
CLDX
$3.27B
$1.66M 0.33%
46,216
-9,996
-18% -$431K
DAKT icon
149
Daktronics
DAKT
$1.04B
$1.63M 0.32%
+287,225
New +$1.17M
MEC icon
150
Mayville Engineering Co
MEC
$617M
$1.62M 0.32%
108,387
-26,079
-19% -$380K

Similar funds

EAM Investors's Q1 2023 Portfolio in Review

As of Q1 2023, EAM Investors held 388 positions worth $509M, up 5.4% from $483M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $46M in Q1 2023, closing 144 positions and reducing 62 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $4.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Assertio worth $4.67M.

  • EAM Investors's largest Q1 2023 buy was Assertio: 48,872 shares worth $4.67M.
  • EAM Investors added most to Harrow in Q1 2023, an estimated $1.31M increase.
  • EAM Investors's biggest Q1 2023 reduction was ADMA Biologics, cutting an estimated $2.47M.
  • EAM Investors fully exited Rhythm Pharmaceuticals in Q1 2023, selling an estimated $4.8M.
  • EAM Investors's ten largest holdings make up 10% of its $509M portfolio in Q1 2023.
  • EAM Investors opened 139 new positions and closed 144 in Q1 2023.
  • EAM Investors's portfolio value rose 5.4% quarter-over-quarter to $509M.

Based on EAM Investors's 13F filing for Q1 2023, filed 15 May 2023.